Evaluation of SARS-CoV-2 (COVID-19) Antibody-containing Plasma thErapy
NCT04361253
·
clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
45
Enrollment
OTHER
Sponsor class
Stopped
Futility
Conditions
COVID
Infectious Disease
Interventions
BIOLOGICAL:
High-Titer COVID-19 Convalescent Plasma (HT-CCP)
BIOLOGICAL:
Standard Plasma (FFP)
Sponsor
Brigham and Women's Hospital